-
Je něco špatně v tomto záznamu ?
αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease
VM. Pozo Devoto, N. Dimopoulos, M. Alloatti, MB. Pardi, TM. Saez, MG. Otero, LE. Cromberg, A. Marín-Burgin, ME. Scassa, GB. Stokin, AF. Schinder, G. Sevlever, TL. Falzone,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- alfa-synuklein chemie genetika metabolismus MeSH
- axonální transport MeSH
- homeostáza * MeSH
- lidé MeSH
- lidské embryonální kmenové buňky metabolismus MeSH
- mitochondriální membrány metabolismus MeSH
- mitochondrie metabolismus MeSH
- mutantní proteiny metabolismus MeSH
- neurony patologie MeSH
- Parkinsonova nemoc genetika patologie MeSH
- proteinové domény MeSH
- velikost organel MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The etiology of Parkinson's disease (PD) converges on a common pathogenic pathway of mitochondrial defects in which α-Synuclein (αSyn) is thought to play a role. However, the mechanisms by which αSyn and its disease-associated allelic variants cause mitochondrial dysfunction remain unknown. Here, we analyzed mitochondrial axonal transport and morphology in human-derived neurons overexpressing wild-type (WT) αSyn or the mutated variants A30P or A53T, which are known to have differential lipid affinities. A53T αSyn was enriched in mitochondrial fractions, inducing significant mitochondrial transport defects and fragmentation, while milder defects were elicited by WT and A30P. We found that αSyn-mediated mitochondrial fragmentation was linked to expression levels in WT and A53T variants. Targeted delivery of WT and A53T αSyn to the outer mitochondrial membrane further increased fragmentation, whereas A30P did not. Genomic editing to disrupt the N-terminal domain of αSyn, which is important for membrane association, resulted in mitochondrial elongation without changes in fusion-fission protein levels, suggesting that αSyn plays a direct physiological role in mitochondrial size maintenance. Thus, we demonstrate that the association of αSyn with the mitochondria, which is modulated by protein mutation and dosage, influences mitochondrial transport and morphology, highlighting its relevance in a common pathway impaired in PD.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19013126
- 003
- CZ-PrNML
- 005
- 20190405092910.0
- 007
- ta
- 008
- 190405s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-017-05334-9 $2 doi
- 035 __
- $a (PubMed)28698628
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pozo Devoto, Victorio Martin $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina. International Clinical Research Center (ICRC), St. Anne's University Hospital, CZ-65691, Brno, Czech Republic.
- 245 10
- $a αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease / $c VM. Pozo Devoto, N. Dimopoulos, M. Alloatti, MB. Pardi, TM. Saez, MG. Otero, LE. Cromberg, A. Marín-Burgin, ME. Scassa, GB. Stokin, AF. Schinder, G. Sevlever, TL. Falzone,
- 520 9_
- $a The etiology of Parkinson's disease (PD) converges on a common pathogenic pathway of mitochondrial defects in which α-Synuclein (αSyn) is thought to play a role. However, the mechanisms by which αSyn and its disease-associated allelic variants cause mitochondrial dysfunction remain unknown. Here, we analyzed mitochondrial axonal transport and morphology in human-derived neurons overexpressing wild-type (WT) αSyn or the mutated variants A30P or A53T, which are known to have differential lipid affinities. A53T αSyn was enriched in mitochondrial fractions, inducing significant mitochondrial transport defects and fragmentation, while milder defects were elicited by WT and A30P. We found that αSyn-mediated mitochondrial fragmentation was linked to expression levels in WT and A53T variants. Targeted delivery of WT and A53T αSyn to the outer mitochondrial membrane further increased fragmentation, whereas A30P did not. Genomic editing to disrupt the N-terminal domain of αSyn, which is important for membrane association, resulted in mitochondrial elongation without changes in fusion-fission protein levels, suggesting that αSyn plays a direct physiological role in mitochondrial size maintenance. Thus, we demonstrate that the association of αSyn with the mitochondria, which is modulated by protein mutation and dosage, influences mitochondrial transport and morphology, highlighting its relevance in a common pathway impaired in PD.
- 650 _2
- $a axonální transport $7 D001370
- 650 12
- $a homeostáza $7 D006706
- 650 _2
- $a lidské embryonální kmenové buňky $x metabolismus $7 D000066449
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a mitochondriální membrány $x metabolismus $7 D051336
- 650 _2
- $a mutantní proteiny $x metabolismus $7 D050505
- 650 _2
- $a neurony $x patologie $7 D009474
- 650 _2
- $a velikost organel $7 D053141
- 650 _2
- $a Parkinsonova nemoc $x genetika $x patologie $7 D010300
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a alfa-synuklein $x chemie $x genetika $x metabolismus $7 D051844
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dimopoulos, Nicolas $u Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Montañeses 2325, Buenos Aires, C1428AQK, Argentina.
- 700 1_
- $a Alloatti, Matías $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina.
- 700 1_
- $a Pardi, María Belén $u Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA) -CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
- 700 1_
- $a Saez, Trinidad M $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina. Instituto de Biología y Medicina Experimental, IBYME (CONICET). Vuelta de obligado 2490, Buenos Aires, CP, 1428, Argentina.
- 700 1_
- $a Otero, María Gabriela $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina.
- 700 1_
- $a Cromberg, Lucas Eneas $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina.
- 700 1_
- $a Marín-Burgin, Antonia $u Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA) -CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
- 700 1_
- $a Scassa, Maria Elida $u Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Montañeses 2325, Buenos Aires, C1428AQK, Argentina.
- 700 1_
- $a Stokin, Gorazd B $u International Clinical Research Center (ICRC), St. Anne's University Hospital, CZ-65691, Brno, Czech Republic.
- 700 1_
- $a Schinder, Alejandro F $u Laboratorio de Plasticidad Neuronal, Fundación Instituto Leloir (IIBBA - CONICET), Av. Patricias Argentinas 435, Buenos Aires, CP C1405BWE, Argentina.
- 700 1_
- $a Sevlever, Gustavo $u Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Montañeses 2325, Buenos Aires, C1428AQK, Argentina.
- 700 1_
- $a Falzone, Tomás Luis $u Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina. tfalzone@fmed.uba.ar. Instituto de Biología y Medicina Experimental, IBYME (CONICET). Vuelta de obligado 2490, Buenos Aires, CP, 1428, Argentina. tfalzone@fmed.uba.ar.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 5042
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28698628 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405092919 $b ABA008
- 999 __
- $a ok $b bmc $g 1392436 $s 1051431
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c 1 $d 5042 $e 20170711 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20190405